Guardant Health, Inc.

Home » Guardant Health, Inc.

IPO

Guardant Health, Inc.

We are a leading precision oncology company focused on helping conquer cancer globally through use of our proprietary blood tests, vast data sets and advanced analytics.

Symbol

GH

Price Range
$15.00 - $17.00

Final Shares
12,500,000

Anticipated Date
TBD

Underwriters
J.P. Morgan, BofA Merrill Lynch, Cowen, Leerink Partners, William Blair

To view the prospectus for Guardant Health, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253